Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC4 | P56524 | 7/20 | 0.42 |
| ▸ | MEF2D | Q14814 | 3/20 | 0.42 |
| ▸ | HDAC1 | Q13547 | 15/20 | 0.42 |
| ▸ | HDAC3 | O15379 | 11/20 | 0.42 |
| ▸ | HDAC8 | Q9BY41 | 10/20 | 0.42 |
| ▸ | HDAC6 | Q9UBN7 | 9/20 | 0.42 |
| ▸ | HDAC5 | Q9UQL6 | 4/20 | 0.42 |
| ▸ | CDK9 | P50750 | 1/20 | 0.42 |
| ▸ | HDAC2 | Q92769 | 9/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | HDAC7 | Q8WUI4 | 2/20 | 0.38 |
| ▸ | HDAC10 | Q969S8 | 2/20 | 0.38 |
| ▸ | HDAC11 | Q96DB2 | 2/20 | 0.38 |
| ▸ | HDAC9 | Q9UKV0 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2705917 | 1.00 | HDAC4 (0.42) | HDAC4MEF2DHDAC1HDAC3HDAC8 | |
| SCHEMBL2705556 | 0.99 | HDAC1 (0.43) | HDAC4MEF2DHDAC1HDAC3HDAC8 | |
| SCHEMBL2705554 | 0.99 | HDAC1 (0.43) | HDAC4MEF2DHDAC1HDAC3HDAC8 | |
| SCHEMBL2706516 | 0.98 | HDAC4 (0.42) | HDAC4MEF2DHDAC1HDAC3HDAC8 | |
| SCHEMBL2706520 | 0.98 | HDAC4 (0.42) | HDAC4MEF2DHDAC1HDAC3HDAC8 | |
| SCHEMBL2704493 | 0.97 | HDAC4 (0.43) | HDAC4MEF2DHDAC1HDAC3HDAC8 | |
| SCHEMBL2731939 | 0.97 | HDAC4 (0.43) | HDAC4MEF2DHDAC1HDAC3HDAC8 | |
| SCHEMBL2705886 | 0.93 | HDAC3 (0.41) | HDAC4MEF2DHDAC1HDAC3HDAC8 | |
| SCHEMBL2705892 | 0.93 | HDAC3 (0.41) | HDAC4MEF2DHDAC1HDAC3HDAC8 | |
| SCHEMBL10072097 | 0.87 | NR1H4 (0.38) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2012025701-A1 | ALPHA, ALPHA - DI SUBSTITUTED GLYCINE ESTER DERIVATIVES AND THEIR USE AS HDAC INHIBITORS | CHROMA THERAPEUTICS LTD. (GB) | 2012-03-01 | — | — | WO | disclosed |
| WO-2012025701-A1 | ALPHA, ALPHA - DI SUBSTITUTED GLYCINE ESTER DERIVATIVES AND THEIR USE AS HDAC INHIBITORS | CHROMA THERAPEUTICS LTD. (GB) | 2012-03-01 | — | — | WO | disclosed |
| WO-2012025701-A1 | ALPHA, ALPHA - DI SUBSTITUTED GLYCINE ESTER DERIVATIVES AND THEIR USE AS HDAC INHIBITORS | CHROMA THERAPEUTICS LTD. (GB) | 2012-03-01 | — | — | WO | disclosed |